Table 6.
Receptor | Residuesa | Cell type | Ligand | Effect | Referenceb |
---|---|---|---|---|---|
CCR2B | N14c | HEK293d | None | = Surface expression | [153] |
CCR5 | S6e (S7e) | HEK293d; HeLad; MFd; Cf2Th-CD4d | None | = Surface expression | [132,133] |
Cf2Th-CD4d | CCL3-4 | + Binding | [133] | ||
HIV-1; SIV | = HIVco | [133] | |||
CXCR2 | N17c; N186c; N197c | Neutrophils | None | + Proteolytic protection | [152] |
CXCL7 | = Granulation, endocytosis, recycling | [152] | |||
CXCR4 | Nc | HEK293Td; HuTK−d | [141,188] | ||
N11; (N176) | CCCd; Mv-1-lud | None | + Surface expression | [145] | |
HIV-2 | 3 HIVco | [145] | |||
BSC-1d | None | = Surface expression | [144] | ||
U373-MG-CD4+d | R5 HIV-1 | 3 HIVco | [144] | ||
X4 HIV-1 | = HIVco | [144] | |||
Cf2-Thd + sCD4 | None | = Surface expression | [146] | ||
X4 HIV-1 | 3 Binding; HIVco | [146] | |||
R5 HIV-1 | 3 Binding; HIVco | [146] | |||
CXCL12 | + Binding; [Ca] | [146] | |||
D6 | N17 | L1.2d | Murine CCL3 | = Binding | [156] |
DARC | N16 | K562d | = Surface expression | [155] | |
CXCL8 | = Binding | [155] |
HIVco: HIV co-receptor activity; MF: primary rhesus macrophages; sCD4: in the presence of soluble CD4; Ca: calcium mobilization. The term inside the paranthesis indicates glycosylation site effectively used, but to lesser extent or with less biological consequences. [Ca] indicates calcium mobilization likely indirect effect, namely due to enhanced ligand binding.
Residues are O-linked or N-linked glycosylated on a specific Ser (S) or Asn (N) residue, respectively. Glycosylation can promote (+), inhibit (−) or not affect the specific effect mentioned.
References include only those in which glycosylation was really demonstrated.
Still unclear whether that particular potential glycosylation site was effectively glycosylated.
Cells were transfected with the corresponding chemokine receptor.
Glycans were sialylated.